The Safety, Pharmacokinetics, and Effects of LGD-4033, a Novel Nonsteroidal Oral, Selective Androgen Receptor Modulator, in Healthy Young Men

BACKGROUND. Concerns about potential adverse effects of testosterone on prostate have motivated the development of selective androgen receptor modulators that display tissue-selective activation of androgenic signaling. LGD-4033, a novel nonsteroidal, oral selective androgen receptor modulator, bind...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Basaria, Shehzad, Collins, Lauren, Dillon, E. Lichar, Orwoll, Katie, Storer, Thomas W., Miciek, Renee, Ulloor, Jagadish, Zhang, Anqi, Eder, Richard, Zientek, Heather, Gordon, Gilad, Kazmi, Syed, Sheffield-Moore, Melinda, Bhasin, Shalender
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2013
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4111291/
https://ncbi.nlm.nih.gov/pubmed/22459616
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/gerona/gls078
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares